Cargando…

Enoxaparin injection for the treatment of high-risk patients with non-ST elevation acute coronary syndrome

Non-ST elevation acute coronary syndrome (NSTE-ACS) refers to a cardiovascular disorder characterized by intracoronary thrombus formation on a disrupted atherosclerotic plaque with partial or transient occlusion. Generation of thrombin resulting from exposure of collagen leads to activation of plate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmidt-Lucke, Caroline, Schultheiss, Heinz-Peter
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2007
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1994029/ https://www.ncbi.nlm.nih.gov/pubmed/17580732

Ejemplares similares

Cost-effectiveness of fondaparinux versus enoxaparin in non-ST-elevation acute coronary syndrome in Canada (OASIS-5)
por: Alfonso Ross Terres, Jorge, et al.
Publicado: (2015)

Effect of subcutaneous Enoxaparin injection duration on bruising size in acute coronary syndrome patients
por: Dehghani, Khadije, et al.
Publicado: (2014)

Non-ST elevation acute coronary syndrome in the elderly
por: Díez-Villanueva, Pablo, et al.
Publicado: (2020)

Continuum of Care for Acute Coronary Syndrome: Optimizing Treatment for ST-Elevation Myocardial Infarction and Non–St-Elevation Acute Coronary Syndrome
por: Gibler, W. Brian, et al.
Publicado: (2018)

Recent developments in diagnosis and risk stratification of non-ST-elevation acute coronary syndrome
por: Aarts, G. W. A., et al.
Publicado: (2020)

Serum cystatin C predicts the risk of non-ST-elevation acute coronary syndrome
por: Dong, Hao, et al.
Publicado: (2023)

Trials, registries and guidelines for non-ST-elevation acute coronary syndromes
por: Verheugt, F. W. A.
Publicado: (2013)

Effect of different revascularization times on intermediate-risk non-ST-elevation acute coronary syndrome
por: Kong, Xiangyong, et al.
Publicado: (2022)

Risk stratification in non-ST elevation acute coronary syndromes: Risk scores, biomarkers and clinical judgment
por: Corcoran, David, et al.
Publicado: (2015)

Tissue characterization of non-culprit intermediate coronary lesions in non ST elevation acute coronary syndromes
por: Elghawaby, Helmy Hassan, et al.
Publicado: (2018)

Effect of COVID-19 on acute treatment of ST-segment elevation and Non-ST-segment elevation acute coronary syndrome in northwestern Switzerland
por: Boeddinghaus, Jasper, et al.
Publicado: (2020)

Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes
por: Røysland, Ragnhild, et al.
Publicado: (2012)

Aggressive therapy for non-ST elevation acute coronary syndromes is highly effective
por: Santos, RA, et al.
Publicado: (2001)

Cognitive Decline in Older Patients With Non‐ST Elevation Acute Coronary Syndrome
por: Gu, Sophie Z., et al.
Publicado: (2019)

Safety of Antiplatelet Pretreatment in Non-ST-segment Elevation Acute Coronary Syndrome
por: Torres-Ruiz, G, et al.
Publicado: (2023)

Predictors of coronary collaterals in patients with non ST-elevated acute coronary syndrome: the paradox of the leukocytes
por: Tenekecioglu, Erhan, et al.
Publicado: (2014)

Safety of the primary percutaneous coronary intervention strategy combining pre-hospital prasugrel, enoxaparin and in-hospital bivalirudin in acute ST-segment elevation myocardial infarction
por: Viikilä, Juho, et al.
Publicado: (2016)

Prognostic value of plasma ST2 in patients with non-ST segment elevation acute coronary syndrome
por: Kokkoz, Çağrı, et al.
Publicado: (2018)

GRACE and TIMI risk scores in predicting the angiographic severity of non-ST elevation acute coronary syndrome
por: Roy, Sharadindu Shekhar, et al.
Publicado: (2018)

Role of the ECG in initial acute coronary syndrome triage: primary PCI regardless presence of ST elevation or of non-ST elevation
por: IJkema, B. B. L. M., et al.
Publicado: (2014)

Elevated Serum Levels of Soluble ST2 Are Associated With Plaque Vulnerability in Patients With Non-ST-Elevation Acute Coronary Syndrome
por: Luo, Guqing, et al.
Publicado: (2021)

Nadroparine calcium or enoxaparine in acute coronary syndrome patients suffering renal insufficiency: The nadroparin versus enoxaparin (NaVe) study design
por: Gurfinkel, Enrique P, et al.
Publicado: (2004)

ANMCO POSITION PAPER: Timing of coronary angiography in non-ST-segment elevation acute coronary syndromes
por: Murrone, Adriano, et al.
Publicado: (2021)

Diffuse ST-segment elevation beyond acute coronary syndrome
por: Zhu, Hai, et al.
Publicado: (2023)

Treatment strategies and outcomes in patients with non-ST-elevation acute coronary syndrome in the Netherlands
por: Damman, P., et al.
Publicado: (2018)

Management of elderly patients with a non-ST-segment-elevation acute coronary syndrome
por: Gimbel, M. E., et al.
Publicado: (2017)

Merits of Invasive Strategy in Diabetic Patients With Non‐ST Elevation Acute Coronary Syndrome
por: Jneid, Hani
Publicado: (2017)

Corrected QT Interval Prolongations in Patients with Non–ST-Elevation Acute Coronary Syndrome
por: Nabati, Maryam, et al.
Publicado: (2018)

Periprocedural anticoagulation in non-ST-segment elevation acute coronary syndrome: time to reassess?
por: Chandiramani, Rishi, et al.
Publicado: (2020)

Revascularization outcomes in diabetic patients presenting with acute coronary syndrome with non-ST elevation
por: Ram, Eilon, et al.
Publicado: (2022)

Antithrombotic PreTreatment and Invasive Strategies in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome
por: Camaro, Cyril, et al.
Publicado: (2020)

Factors associated with bleeding events from enoxaparin used for patients with acute coronary syndrome
por: Weerasaksanti, Adisak, et al.
Publicado: (2023)

Plasma Granzyme B in ST Elevation Myocardial Infarction versus Non-ST Elevation Acute Coronary Syndrome: Comparisons with IL-18 and Fractalkine
por: El-Mesallamy, Hala O., et al.
Publicado: (2013)

Clinical Features and Prognosis of Patients With Coronary Spasm–Induced Non–ST‐Segment Elevation Acute Coronary Syndrome
por: Nakayama, Naoki, et al.
Publicado: (2014)

Coronary Atherosclerotic Plaque Vulnerability Rather than Stenosis Predisposes to Non-ST Elevation Acute Coronary Syndromes
por: Laimoud, Mohamed, et al.
Publicado: (2019)

Temporal trends and inequalities in coronary angiography utilization in the management of non-ST-Elevation acute coronary syndromes in the U.S.
por: Rashid, Muhammad, et al.
Publicado: (2019)

Multivessel versus Culprit-Only Percutaneous Coronary Intervention in Patients with Non-ST-Elevation Acute Coronary Syndrome
por: Pustjens, Tobias F. S., et al.
Publicado: (2022)

When is the Best Time for the Second Antiplatelet Agent in Non-St Elevation Acute Coronary Syndrome?
por: Silva, Pedro Gabriel Melo de Barros e, et al.
Publicado: (2016)

T‐Wave Abnormality as Electrocardiographic Signature of Myocardial Edema in Non‐ST‐Elevation Acute Coronary Syndromes
por: Cardona, Andrea, et al.
Publicado: (2018)

Prognosis Impact of Diabetes in Elderly Women and Men with Non-ST Elevation Acute Coronary Syndrome
por: Díez-Villanueva, Pablo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_16rebf0is5ken8al9cc3a3q4sq